Sangamo Therapeutics Stock Today
| SGMO Stock | USD 0.54 0.01 1.89% |
Performance3 of 100
| Odds Of DistressOver 80
|
Sangamo Therapeutics is selling at 0.54 as of the 8th of May 2024; that is 1.89 percent increase since the beginning of the trading day. The stock's open price was 0.53. Sangamo Therapeutics has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Sangamo Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of March 2024 and ending today, the 8th of May 2024. Click here to learn more.
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. Sangamo Therapeutics, Inc. The company has 207.5 M outstanding shares of which 13.25 M shares are at this time shorted by private and institutional investors with about 5.95 trading days to cover. More on Sangamo Therapeutics
Moving together with Sangamo Stock
| 0.63 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
Moving against Sangamo Stock
| 0.69 | DOMH | Dominari Holdings | PairCorr |
| 0.68 | YS | YS Biopharma | PairCorr |
| 0.61 | VERU | Veru Inc Financial Report 9th of May 2024 | PairCorr |
| 0.44 | VALN | Valneva SE ADR | PairCorr |
Follow Valuation Odds of Bankruptcy
Financial Report 13th of May 2024
Sangamo Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sangamo Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sangamo Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President | Jason Fontenot |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Sangamo Therapeutics (SGMO) is traded on NASDAQ Exchange in USA. It is located in 501 Canal Blvd, Richmond, CA, United States, 94804 and employs 405 people. Sangamo Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 112.03 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sangamo Therapeutics's market, we take the total number of its shares issued and multiply it by Sangamo Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sangamo Therapeutics conducts business under Biotechnology sector and is part of Health Care industry. The entity has 207.5 M outstanding shares of which 13.25 M shares are at this time shorted by private and institutional investors with about 5.95 trading days to cover.
Sangamo Therapeutics currently holds about 315.72 M in cash with (224.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Sangamo Therapeutics Probability Of Bankruptcy
Ownership AllocationSangamo Therapeutics shows a total of 207.5 Million outstanding shares. Over half of Sangamo Therapeutics' outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Sangamo Therapeutics. Please watch out for any change in the institutional holdings of Sangamo Therapeutics as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sangamo Ownership Details
Sangamo Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Sangamo Therapeutics jumping above the current price in 90 days from now is about 79.77%. The Sangamo Therapeutics probability density function shows the probability of Sangamo Therapeutics stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.3167. This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Sangamo Therapeutics will likely underperform. Additionally, sangamo Therapeutics has an alpha of 0.4226, implying that it can generate a 0.42 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Sangamo Therapeutics to move above the current price in 90 days from now is about 79.77 (This Sangamo Therapeutics probability density function shows the probability of Sangamo Stock to fall within a particular range of prices over 90 days) .
Sangamo Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Sangamo Therapeutics market risk premium is the additional return an investor will receive from holding Sangamo Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Sangamo Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Sangamo Therapeutics' alpha and beta are two of the key measurements used to evaluate Sangamo Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Risk Adjusted Performance | 0.039 | |||
| Jensen Alpha | 0.4226 | |||
| Total Risk Alpha | (0.71) | |||
| Sortino Ratio | 0.0523 |
Sangamo Stock Against Markets
Picking the right benchmark for Sangamo Therapeutics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Sangamo Therapeutics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Sangamo Therapeutics is critical whether you are bullish or bearish towards Sangamo Therapeutics at a given time. Please also check how Sangamo Therapeutics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sangamo Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Sangamo Therapeutics Corporate Management
Elected by the shareholders, the Sangamo Therapeutics' board of directors comprises two types of representatives: Sangamo Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sangamo. The board's role is to monitor Sangamo Therapeutics' management team and ensure that shareholders' interests are well served. Sangamo Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sangamo Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Phillip Ramsey | Head Operations | Profile | |
| David Ojala | Scientist Research | Profile | |
| Mark McClung | Ex COO | Profile | |
| Stephanie CLP | Head Management | Profile | |
| Whitney Jones | VP Officer | Profile | |
| Andrew Ramelmeier | Ex Operations | Profile |
How to buy Sangamo Stock?
Before investing in Sangamo Therapeutics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Sangamo Therapeutics. To buy Sangamo Therapeutics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Sangamo Therapeutics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Sangamo Therapeutics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Sangamo Therapeutics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Sangamo Therapeutics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Sangamo Therapeutics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Sangamo Stock please use our How to Invest in Sangamo Therapeutics guide.
Already Invested in Sangamo Therapeutics?
The danger of trading Sangamo Therapeutics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Sangamo Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Sangamo Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Sangamo Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Sangamo Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sangamo Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sangamo Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sangamo Therapeutics Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sangamo Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. To learn how to invest in Sangamo Stock, please use our How to Invest in Sangamo Therapeutics guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Sangamo Stock analysis
When running Sangamo Therapeutics' price analysis, check to measure Sangamo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sangamo Therapeutics is operating at the current time. Most of Sangamo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sangamo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sangamo Therapeutics' price. Additionally, you may evaluate how the addition of Sangamo Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is Sangamo Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sangamo Therapeutics. If investors know Sangamo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sangamo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Sangamo Therapeutics is measured differently than its book value, which is the value of Sangamo that is recorded on the company's balance sheet. Investors also form their own opinion of Sangamo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sangamo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sangamo Therapeutics' market value can be influenced by many factors that don't directly affect Sangamo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sangamo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sangamo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sangamo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.